Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts

STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro

(2013) Haixiao Wang et al.   BMB Reports

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab

(2013) F Loupakis et al.   BRITISH JOURNAL OF CANCER

Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?

(2013) Tom Donnem et al.   Cancer Medicine

The cancer stem cell niche(s): The crosstalk between glioma stem cells and their microenvironment

(2012) Alina Filatova et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia

(2012) S. J. Conley et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effects of Novel Angiogenesis Inhibitors for the Treatment of Cancer on the Cardiovascular System

(2011) Babak Nazer et al.   CIRCULATION

Evolution and roles of stanniocalcin

(2011) B.H.Y. Yeung et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

The cancer stem cell: premises, promises and challenges

(2011) Hans Clevers   NATURE MEDICINE

Treatment of Metastatic Colorectal Cancer

(2011) Janine M. Davies et al.   SEMINARS IN ONCOLOGY

Clinical Significance of Stanniocalcin 2 as a Prognostic Marker in Gastric Cancer

(2010) Takehiko Yokobori et al.   ANNALS OF SURGICAL ONCOLOGY

Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics

(2010) Qun Lin et al.   CANCER BIOLOGY & THERAPY

Stanniocalcin-2 promotes epithelial–mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells

(2010) Alice Y.S. Law et al.   EXPERIMENTAL CELL RESEARCH

Colon Cancer Stem Cells: Promise of Targeted Therapy

(2010) Matilde Todaro et al.   GASTROENTEROLOGY

Disease Course Patterns After Discontinuation of Bevacizumab: Pooled Analysis of Randomized Phase III Trials

(2010) David Miles et al.   JOURNAL OF CLINICAL ONCOLOGY

Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade glioma

(2010) Richard M. Zuniga et al.   JOURNAL OF NEURO-ONCOLOGY

Colorectal cancer

(2010) David Cunningham et al.   LANCET

Hypoxia-Inducible Factors and the Response to Hypoxic Stress

(2010) Amar J. Majmundar et al.   MOLECULAR CELL

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

(2009) Marta Pàez-Ribes et al.   CANCER CELL

Oncogenic KRAS and BRAF Differentially Regulate Hypoxia-Inducible Factor-1  and -2  in Colon Cancer

(2009) H. Kikuchi et al.   CANCER RESEARCH

Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis

(2009) E. H. Huang et al.   CANCER RESEARCH

Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer

(2009) Kenji Tamura et al.   CANCER SCIENCE

Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia

(2009) Alice Y.S. Law et al.   EXPERIMENTAL CELL RESEARCH

Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma

(2009) Sonja Volland et al.   INTERNATIONAL JOURNAL OF CANCER

Clinicopathological significance ofstanniocalcin 2gene expression in colorectal cancer

(2009) Keisuke Ieta et al.   INTERNATIONAL JOURNAL OF CANCER

Reversible tumor growth acceleration following bevacizumab interruption in metastatic colorectal cancer patients scheduled for surgery

(2008) W. Cacheux et al.   ANNALS OF ONCOLOGY

Tumor dormancy: Elevated expression of stanniocalcins in late relapsing breast cancer

(2008) Kristiina Joensuu et al.   CANCER LETTERS

TSU68 Prevents Liver Metastasis of Colon Cancer Xenografts by Modulating the Premetastatic Niche

(2008) M. Yamamoto et al.   CANCER RESEARCH

Identification of Stanniocalcin 2 as Prognostic Marker in Renal Cell Carcinoma

(2008) Hellmuth-A. Meyer et al.   EUROPEAN UROLOGY

Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells

(2008) Alice Y.S. Law et al.   EXPERIMENTAL CELL RESEARCH